Progen

What Progen does

PROGEN is a biotechnology company founded in 1983 in Heidelberg, Germany, that manufactures analytical tools, antibodies, ELISA kits, and density gradient media for gene therapy research and viral vector bioprocessing. Its technology is built on proprietary antibodies that bind to specific conformational epitopes generated by AAV (Adeno-Associated Virus) capsid assembly, enabling serotype-specific quantification across multiple variants (AAV1, 2, 3, 5, 6, 8, 9, AAVrh10, AAVrh74). The portfolio is organized around three vector delivery platforms: AAV tools (Titration ELISAs, Xpress ELISAs delivering results in ~2 hours vs. 4.5 hours, Anti-pan AAV antibodies, Dip'n'Check lateral flow assays, and AAV reference standards), LVV tools (Lenti p24 Xpress Assay, launched 2026, quantifying p24 in 20 minutes from crude to purified samples), and LNP delivery kits. Manufacturing is DIN EN ISO 13485 certified, performed in Germany, and calibrated against ATCC international gold standard reference materials (AAV2, AAV8) and proprietary internal gold standards.

The company operates a product-led, catalog-based go-to-market selling off-the-shelf research reagents directly through an e-commerce storefront, supplemented by a wholly-owned US subsidiary (PROGEN Biotech Inc., East Hartford, CT) for North American sales and a global distributor network for other regions. Pricing is quote-based and not publicly disclosed; revenue mechanics are one-time purchases with repeat orders from established research customers. Primary customer segments are academic and institutional gene therapy researchers plus biopharmaceutical manufacturers and CDMOs producing AAV-based therapies, with secondary segments in lentiviral vector and LNP-based therapy research. The company is privately held and appears to be management/founder-influenced, led by co-CEO Katja Betts with a small management team (Head of Production, Head of R&D, Product Manager, Account Manager), consistent with the disclosed 11–50 employee headcount.

Name

Progen

Legal name

PROGEN INC

Website

https://progen.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

PROGEN is a Heidelberg-based biotech founded in 1983 that manufactures ELISA kits, antibodies, and analytical tools for quantifying AAV, lentiviral, and lipid nanoparticle gene therapy vectors, serving academic researchers and viral vector biomanufacturers worldwide.

Ownership category

akta.pro rank

Product category

Biotech Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Gene Therapy Analytical Testing & QC (potency, vg/ddPCR, infectivity, RCL/RCA) (HLAAACAK)

akta.pro secondary industry

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)

Keywords

• Gene therapy reagents
• AAV ELISA kits
• Lentiviral vector tools
• Antibody manufacturing
• Density gradient media

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Research Tool and Reagent Sales: Sale of analytical tools, ELISA kits, antibodies, and density gradient media for gene therapy research. Products are sold as off-the-shelf items with immediate availability from Germany or US subsidiary. One-time purchase model with repeat orders from established customers.
2. Custom and Specialized Reagents: Sale of specialized reagents including serotype-specific kit controls, standard materials (eGFP, Rluc), ELISA controls, VP/Rep protein standards, and antigens for diagnostic assays.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

PROGEN manufactures and sells analytical tools, ELISA kits, antibodies, and density gradient media for gene therapy research, with a primary focus on the characterization and quantification of AAV (Adeno-Associated Virus), LVV (Lentiviral Vectors), and LNP (Lipid Nanoparticle) delivery platforms. Products are manufactured in Germany under DIN EN ISO 13485 quality certification and shipped worldwide through direct e-commerce, a US subsidiary, and a global distributor network.

Product overview

PROGEN is a biotechnology company manufacturing high-quality analytical tools and antibodies for gene therapy research since 1983. The company operates as a unified product portfolio organized around three core vector delivery platforms: AAV (Adeno-Associated Virus) tools including ELISAs (Titration, Xpress, Human Antibody, Endonuclease, Simple Plex), standards, antibodies, and Dip'n'Check lateral flow assays; LVV (Lentiviral Vector) tools including the Lenti p24 Xpress Assay; and LNP (Lipid Nanoparticle) delivery kits. The portfolio also includes complementary product lines in density gradient media (OptiPrep, Nycodenz, LymphoPrep, PolymorphPrep), Hyperphage, and broad antibody categories (Tissue, Viruses & Pathogens, Tag Antibodies, Diagnostic Assays). Products are DIN EN ISO 13485 certified, manufactured in Germany, and distributed worldwide with scientific support.

Differentiator

Problem solved

Functional benefit

Products and services

• AAV Titration ELISAs Serotype-specific ELISA kits (AAV1, 2, 3, 5, 6, 8, 9, rh10) for quantifying AAV capsids based on antibodies binding to specific conformational epitopes generated by capsid assembly. Each kit includes one pre-coated microtiter plate with capacity for 40 duplicate sample measurements. Kit controls are standardized against ATCC international gold standard material (AAV2 and AAV8) or PROGEN internal gold standards.
• AAV Xpress ELISA Accelerated AAV ELISA workflow that delivers results in approximately 2 hours compared to 4.5 hours for standard titration ELISAs. Available for AAV serotypes 2, 5, 6, 8, and 9 with the same accuracy and reliability as standard kits using adjusted kit components.
• AAV Human Antibody ELISA ELISA kit for determining anti-AAV antibodies in Human Sera across multiple serotypes, used in gene therapy clinical research and patient screening.
• Endonuclease ELISA ELISA kit for monitoring endonuclease activity to support consistent AAV production and process control.
• Simple Plex Assays Assays for detecting intact AAV capsids in bioprocess samples, used for process monitoring and lot release.
• AAV Dip'n'Check Lateral Flow Assay Quick lateral flow assay for estimating AAV titer within 20 minutes, used to guide optimal sample dilution for downstream ELISA testing and ensure samples fall within the assay's dynamic range.
• AAV Standards Standard reference materials for AAV titer standardization, including Empty Capsids, Standard Material (eGFP), Standard Material (Rluc), ELISA Controls, VP Protein Standards, and Rep Protein Standards.
• AAV Antibodies Portfolio of AAV detection antibodies including Particle Antibodies, Anti-pan AAV Antibodies (detecting multiple serotypes with a single reagent), Human Chimeric AAV Antibodies, Capsid Protein Antibodies, and Replicase Antibodies for various AAV research applications.
• Lenti p24 Xpress Assay Automated lentiviral vector (LVV) quantification assay delivering p24 results in 20 minutes from crude to purified samples, used by gene therapy and cell therapy researchers for lentiviral vector titer determination.
• LNP Delivery Kits Tools and kits for lipid nanoparticle research and delivery applications in non-viral gene therapy, supporting LNP characterization, delivery optimization, and extrahepatic targeting research.
• OptiPrep Iodixanol-based density gradient medium produced by Serumwerk Bernburg AG and distributed by PROGEN, recommended for AAV particle purification in gene therapy manufacturing workflows.
• Nycodenz Iohexol-based density gradient medium for cell and particle separation applications in research and manufacturing workflows.
• LymphoPrep Density gradient medium for lymphocyte isolation from whole blood used in immunology and cell therapy research.
• PolymorphPrep Density gradient medium for rapid isolation of polymorphonuclear granulocytes and erythrocytes from whole blood used in immunology and cell research applications.
• Hyperphage

Quantifiable outcome

• Results in approximately 2 hours with AAV Xpress ELISA
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Serumwerk Bernburg AGcoreStrategic or Co-development PartnerPROGEN recommends and distributes OptiPrep produced by Serumwerk Bernburg AG for AAV particle purification. OptiPrep is a density gradient medium used in the purification workflow of gene therapy vectors.
• ATCC (American Type Culture Collection)coreStrategic or Co-development PartnerATCC provides international gold standard reference materials for AAV2 and AAV8 calibration. PROGEN's ELISA kits are calibrated against these standardized reference materials to ensure reproducibility and comparability across laboratories.
• ViralgenminorStrategic or Co-development PartnerGene therapy viral vector manufacturing company providing testimonial endorsement of PROGEN's products and support services. Represents a long-term collaborative relationship in the gene therapy space.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Cytiva (Danaher): Large bioprocess and life sciences tools provider (formerly GE Healthcare Life Sciences) offering AAV and LVV manufacturing solutions including analytical reagents and QC kits. Comparable as a supplier of gene therapy manufacturing consumables, though Cytiva's portfolio extends across filtration, chromatography, and cell culture media.
• Bio-Rad Laboratories: Major life sciences tools manufacturer with a broad ELISA, antibody, and protein quantification portfolio serving gene therapy and bioprocess QC markets. Directly comparable because Bio-Rad's reagents are used alongside PROGEN's in AAV characterization workflows, though Bio-Rad operates at much greater scale across many research areas.
• Merck KGaA / MilliporeSigma: Global life sciences supplier with deep ELISA, antibody, and gene therapy analytical portfolios including AAV titer assays and LVV quantification tools. Comparable because it sells directly competing ELISA kits and reference standards to the same gene therapy manufacturing customers.

Others

• Addgene: Nonprofit plasmid and viral vector repository serving the gene therapy research community. Comparable as an ecosystem participant reaching the same AAV/LVV researcher customer base, though Addgene distributes research materials rather than analytical QC tools.

Direct peers

• System Biosciences (SBI): Specialty life sciences company offering lentiviral packaging, AAV production systems, and gene therapy analytical reagents. Directly comparable as a smaller peer competing in the LVV and AAV reagent and tools market.
• Cell Biolabs: Specialty reagent company offering AAV and lentiviral titer ELISA kits, neutralization assays, and gene therapy research tools. Most direct comparable given overlapping product categories (AAV/LVV quantification kits) and similar customer base of academic and biopharma gene therapy researchers.
• Takara Bio: Gene therapy tools provider offering lentiviral vector production systems, AAV titration kits, and related reagents. Comparable because it directly competes in the LVV and AAV reagent space with PROGEN, particularly for p24 quantification and AAV capsid titer products.

Emerging players

• ACROBiosystems: Growing protein and reagent supplier with expanding AAV, lentiviral, and gene therapy analytical offerings. Comparable as an emerging competitor in the AAV/LVV analytical reagents space, though with a broader protein catalog and more aggressive expansion into biologics QC reagents.
• Sino Biological: China-based reagent company offering recombinant proteins, antibodies, and ELISA kits with growing presence in gene therapy research tools. Comparable as an emerging competitor in life sciences reagents, though primarily serving different geographies with cost-competitive alternatives to PROGEN.
• Virovek: AAV contract manufacturer and reagent supplier providing AAV production services and related analytical tools. Comparable as a niche AAV-focused player serving gene therapy developers with overlapping customer relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/progen_biotech
• Facebookfacebook.com/ProgenBiotechnik

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Progen